PAAMCP
IONS icon

Pacific Alternative Asset Management Company (PAAMCO)’s Ionis Pharmaceuticals IONS Stock Holding History

Pacific Alternative Asset Management Company (PAAMCO)’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,190
Closed -$213K – 226
2014
Q2 		$213K Buy
+6,190
New +$195K 0.03% 182

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacific Alternative Asset Management Company (PAAMCO)'s IONS Position: Q3 2014 in Review

Pacific Alternative Asset Management Company (PAAMCO) sold out of Ionis Pharmaceuticals (IONS) in Q3 2014, closing a stake of 6,190 shares — an estimated $213K sold.

Pacific Alternative Asset Management Company (PAAMCO) first reported a position in IONS in Q2 2014 and held it in 1 quarter. The position peaked at $213K in Q2 2014. 240 funds tracked by Wall St. Rank hold IONS as of Q3 2014.

  • Pacific Alternative Asset Management Company (PAAMCO) reported no remaining Ionis Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Pacific Alternative Asset Management Company (PAAMCO) sold 6,190 Ionis Pharmaceuticals shares in Q3 2014, an estimated $213K.
  • Pacific Alternative Asset Management Company (PAAMCO) first reported a position in Ionis Pharmaceuticals in Q2 2014 and held it in 1 quarter.
  • Pacific Alternative Asset Management Company (PAAMCO)'s Ionis Pharmaceuticals position peaked at $213K in Q2 2014.
  • 240 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2014.

Based on Pacific Alternative Asset Management Company (PAAMCO)'s 13F filing for Q3 2014, filed 13 Nov 2014.